B
BGT
BIO-GENE TECHNOLOGY
0.029
0.0000.00%Suspension07:00 05/22 AEST
OPEN/PREV CLOSE--/0.029
TODAY RANGE-
VOL--
MARKET CAP8.85M
52 WEEK RANGE0.016-0.061
AVG VOL (3M)178.42K
% TURNOVER0.42%
TURNOVER132
P/E (TTM)-3.0208
% RANGE--
EPS(TTM)-0.0096
P/E(FORWARD)0.967
P/B7.63
BVPS0.0038
DIVIDEND--
P/S18.13
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP3.92M
SHARES OUTSTANDING305.06M
NEXT EARNINGS07/29-08/03
FREE FLOAT135.08M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
ASX·2d ago
Trading Halt-BGT.AX
ASX·05/05 23:51
Key insecticide combinations patent allowed in the US
ASX·04/27 00:00
BIO-GENE TECHNOLOGY LIMITED Prelim Q3
ASX·04/19 23:33
Investor Presentation
ASX·04/13 23:35
Change of Auditor
ASX·03/26 01:22
NWR Healthcare Conference Presentation
ASX·03/19 23:00
Bio-Gene to present at NWR Healthcare Conference
ASX·03/15 21:20
Sumitomo & Nakashima to launch Qcide products in Japan
ASX·03/09 22:30
Update on Qcide Production
ASX·03/02 22:07
Regulatory Development of Flavocide
ASX·02/23 22:37
Appendix 4D and Half-Year Accounts 31 December 2025
ASX·02/12 22:47
Flavocide Acute Neurotoxicity Study Underway
ASX·02/08 22:34
Flavocide Reproductive Toxicity Study Underway
ASX·02/01 22:12
CFO and Company Secretary Appointment/Resignation
Same Industry
Name/Symbol
Change%
Price
No data yet, let's see others